1
An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies
Condition(s):Solid Tumors and Hematologic MalignancyLast Updated:June 14, 2019Terminated
Hide Studies Not Open or Pending
Condition(s):Solid Tumors and Hematologic MalignancyLast Updated:June 14, 2019Terminated
Condition(s):Last Updated:April 1, 2019No longer available
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.